Viatris is a global pharmaceutical company that produces generic, branded, and complex generic medicines across a broad range of therapeutic areas.
| Filer | 13FScore | This quarter | Shares | Value | % of their book |
|---|---|---|---|---|---|
| David Einhorn / Greenlight | 50 | New buy | 1,817,570 | $24,555,371 | 0.8% |
| Ancora | 42 | Holds (flat) | 1,313 | $17,739 | 0.0% |
| Larry Robbins / Glenview | 58 | Trimmed -18% | 9,087,244 | $122,768,666 | 3.1% |
| Bridgewater | 55 | Trimmed -49% | 725,884 | $9,806,693 | 0.0% |
Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-07-20.